SecSonar.com

Sunshine Biopharma, Inc. (SBFM)

Sunshine Biopharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sunshine Biopharma, Inc. (SBFM) is a Drug Manufacturers - Specialty & Generic company based in CA with a market capitalization of $1.4M. Revenue grew 4.1% year-over-year and free cash flow was negative at -$5.5M. This page tracks SBFM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 52 employees · IPO Feb 15, 2022

Valuation

Valuation & price

$0.28 · as of May 17, 2026 · -98.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.06

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$22.00$12.02$2.04Jul 25Dec 25Jul 26Jul 7, 25$14.70Jul 9, 25$15.60Jul 11, 25$15.40Jul 15, 25$15.10Jul 17, 25$16.00Jul 21, 25$15.60Jul 23, 25$15.80Jul 25, 25$15.70Jul 29, 25$15.10Jul 31, 25$14.40Aug 4, 25$14.60Aug 6, 25$14.00Aug 11, 25$14.30Aug 13, 25$15.00Aug 15, 25$14.90Aug 19, 25$14.20Aug 21, 25$14.20Aug 25, 25$14.00Aug 27, 25$14.80Aug 29, 25$14.40Sep 3, 25$14.30Sep 5, 25$13.60Sep 9, 25$14.30Sep 11, 25$14.80Sep 16, 25$14.90Sep 18, 25$14.70Sep 22, 25$15.10Sep 24, 25$15.60Sep 26, 25$14.60Sep 30, 25$14.90Oct 2, 25$15.10Oct 6, 25$15.30Oct 8, 25$16.80Oct 10, 25$15.50Oct 14, 25$18.00Oct 16, 25$22.00Oct 21, 25$19.20Oct 23, 25$18.50Oct 27, 25$19.60Oct 29, 25$17.60Oct 31, 25$17.70Nov 4, 25$16.90Nov 6, 25$17.90Nov 10, 25$17.20Nov 12, 25$17.70Nov 14, 25$16.30Nov 18, 25$14.90Nov 20, 25$13.90Nov 25, 25$13.90Nov 28, 25$14.50Dec 2, 25$14.80Dec 4, 25$14.40Dec 8, 25$14.50Dec 10, 25$14.60Dec 12, 25$13.40Dec 16, 25$13.80Dec 18, 25$13.70Dec 22, 25$13.80Dec 24, 25$13.10Dec 29, 25$12.30Jan 2, 26$12.80Jan 6, 26$13.30Jan 8, 26$13.70Jan 12, 26$12.70Jan 14, 26$12.30Jan 16, 26$12.20Jan 21, 26$12.60Jan 23, 26$12.30Jan 27, 26$12.80Jan 29, 26$12.40Feb 2, 26$12.30Feb 4, 26$12.10Feb 9, 26$11.90Feb 11, 26$11.90Feb 13, 26$11.70Feb 18, 26$11.80Feb 20, 26$11.80Feb 24, 26$11.70Feb 26, 26$12.30Mar 2, 26$11.60Mar 4, 26$11.50Mar 6, 26$11.10Mar 10, 26$11.90Mar 12, 26$11.10Mar 17, 26$11.10Mar 19, 26$10.90Mar 23, 26$10.20Mar 25, 26$10.30Mar 27, 26$10.20Mar 31, 26$10.40Apr 2, 26$10.40Apr 7, 26$10.40Apr 9, 26$10.40Apr 13, 26$9.90Apr 15, 26$10.00Apr 17, 26$10.30Apr 22, 26$9.92Apr 24, 26$10.00Apr 28, 26$9.80Apr 30, 26$9.62May 4, 26$11.00May 6, 26$10.80May 8, 26$10.50May 12, 26$10.50May 14, 26$4.69May 18, 26$5.10May 20, 26$3.67May 22, 26$4.81May 28, 26$3.17Jun 1, 26$2.39Jun 3, 26$2.66Jun 5, 26$2.46Jun 9, 26$2.28Jun 11, 26$2.37Jun 15, 26$2.28Jun 17, 26$2.12Jun 22, 26$2.05Jun 24, 26$2.04Jun 26, 26$2.18Jul 2, 26$2.11
$2.0452-week range$22.00
Loading valuation history…

Fundamentals

Key fundamentals

$1.4M

Market cap

4.1%

Revenue growth (YoY)

32.8%

Gross margin

-$5.5M

Free cash flow (USD)

-$8.3M

Net debt

Net cash position

492.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$447.2KFY 2019$21.1KFY 2020$71.4KFY 2021$228.4KFY 2022$4.3MFY 2023$24.1MFY 2024$34.9MFY 2025$36.3M
$0$36.3M

Free cash flow by year

2016 → 2025

FY 2016$-317.6KFY 2017$-547.2KFY 2018$-531.7KFY 2019$-496.7KFY 2020$-658.5KFY 2021$-1.8MFY 2022$-5.6MFY 2023$-9.6MFY 2024$-14.9MFY 2025$-5.5M
-$317.6K-$5.5M

Gross margin by year

2021 → 2025

FY 202148.4%FY 202239.0%FY 202334.6%FY 202430.6%FY 202532.8%
48.4%32.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventShareholder ApprovalMay 29, 2026Filing
  • 8-K eventBest Efforts Secondary OfferingMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseApr 9, 2026Filing
  • Annual report10-K FiledApr 3, 2026Filing

Questions

Frequently asked questions

What is Sunshine Biopharma, Inc.'s market cap?

Sunshine Biopharma, Inc. (SBFM) has a market capitalization of $1.4M.

What is SBFM's P/E ratio?

A meaningful P/E ratio is not available for SBFM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SBFM's price-to-book (P/B) ratio?

SBFM trades at 0.06 times book value per share.

Are insiders buying SBFM stock?

SEC Form 4 filings show no open-market insider buys at Sunshine Biopharma, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

IMCC

IM Cannabis Corp.

$1M

UPC

Universe Pharmaceuticals Inc.

$1.8M

SNOA

Sonoma Pharmaceuticals, Inc.

$2M

AKAN

Akanda Corp.

$706.9K

PRPH

ProPhase Labs, Inc.

$457.1K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.